NCT06869577Not yet recruiting
A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
Project SUGRI - a Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
Source: ClinicalTrials.gov · Last updated 29 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Feasibility test and evaluation of a group intervention for caregivers to patients diagnosed with a glioblastoma.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- First submitted
- 3 Jan 2025
- Start date
- 1 May 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Diseases
- Glioblastoma
- NCT number
- NCT06869577
What you commit to
- Study type: Interventional
- Planned participants: 24
- From 1 May 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participants who do not understand, read, and speak Danish.
Who the study is looking for
- Family caregivers (≥18 years) to patients (≥18 years) diagnosed with a GBM grade IV or diffuse astrocytoma grade IV offered Stupps treatment regime.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Copenhagen University Hospital, Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
Related publications
- A Supportive Group Intervention for Caregivers to Patients Diagnosed With Glioblastoma: Protocol for the SUGRI Study.JMIR Res Protoc · 2026 · PMID 41812182
This page is information, not medical advice. Discuss any trial with your doctor.